ATE365033T1 - Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung - Google Patents

Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung

Info

Publication number
ATE365033T1
ATE365033T1 AT94925418T AT94925418T ATE365033T1 AT E365033 T1 ATE365033 T1 AT E365033T1 AT 94925418 T AT94925418 T AT 94925418T AT 94925418 T AT94925418 T AT 94925418T AT E365033 T1 ATE365033 T1 AT E365033T1
Authority
AT
Austria
Prior art keywords
ester
hyaluronic acid
acid
derivative
partial
Prior art date
Application number
AT94925418T
Other languages
English (en)
Inventor
Luca Benedetti
Lanfranco Callegaro
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11390425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365033(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Application granted granted Critical
Publication of ATE365033T1 publication Critical patent/ATE365033T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT94925418T 1993-07-30 1994-07-29 Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung ATE365033T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD930165A IT1263394B (it) 1993-07-30 1993-07-30 Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati

Publications (1)

Publication Number Publication Date
ATE365033T1 true ATE365033T1 (de) 2007-07-15

Family

ID=11390425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925418T ATE365033T1 (de) 1993-07-30 1994-07-29 Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung

Country Status (9)

Country Link
US (1) US6509322B2 (de)
EP (1) EP0716596B8 (de)
AT (1) ATE365033T1 (de)
AU (1) AU7534194A (de)
DE (1) DE69434992T2 (de)
ES (1) ES2288298T3 (de)
IT (1) IT1263394B (de)
PT (1) PT716596E (de)
WO (1) WO1995003786A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2322864A (en) * 1997-03-07 1998-09-09 Polybiomed Ltd Gel for application to the human or animal body
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
EP1443944A1 (de) * 2001-11-12 2004-08-11 Johannes Reinmüller Pharmazeutische anwendungen von hyaluronsäure-präparaten
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US7262179B2 (en) 2003-05-28 2007-08-28 Bristol-Myers Squibb Company Wound care compositions
US20050220721A1 (en) * 2004-03-17 2005-10-06 Kablik J J Anti-adhesion spraying
US20050272695A1 (en) * 2004-05-27 2005-12-08 Novozymes Biopolymer A/S Fast dissolving dried hyaluronic acid product
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
EP2063859B1 (de) * 2006-09-13 2017-01-18 Enhance Skin Products Inc. Kosmetische zusammensetzung zur behandlung der haut und verfahren dafür
DE102006049580A1 (de) * 2006-10-20 2008-04-24 Rochel, Michael, Dr. med. Topische Zusammensetzung zur Behandlung von Ekzemen
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
CN101455857B (zh) * 2007-12-11 2014-03-12 纪欣 生物相容性变性淀粉海绵
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8679470B2 (en) 2008-11-28 2014-03-25 Luromed Llc Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
PL2387390T3 (pl) * 2009-01-13 2013-12-31 Pergamum Ab Zawierające kwas hialuronowy kompozycje do leczenia ran, blizn oraz zrostów powstających po zabiegach chirurgicznych
US8247390B2 (en) * 2009-09-28 2012-08-21 Luromed Llc Modified hydrophilic polymers containing hydrophobic groups
JP2013533362A (ja) * 2010-07-29 2013-08-22 ユニバーシティ オブ ジュネーブ ヒアルロン酸の疎水性有機化合物とのエステル化用のプロセス
IT1402786B1 (it) 2010-11-19 2013-09-18 Fidia Farmaceutici Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
PL2701729T3 (pl) 2011-04-27 2020-01-31 Biom'up Kompozycje hemostatyczne
US9956387B2 (en) * 2011-07-08 2018-05-01 Timothy Brown Article of clothing for applying a pharmaceutical, a pharmaceutical delivery kit and method
US10400105B2 (en) 2015-06-19 2019-09-03 The Research Foundation For The State University Of New York Extruded starch-lignin foams
BR112019001894B1 (pt) 2016-08-12 2022-06-14 Biom'up France SAS Kit para preparar uma composição fluida hemostática e método para preparar uma composição fluida hemostática com o kit

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138572B1 (de) 1983-10-11 1990-07-25 FIDIA S.p.A. Fraktionen von Hyaluronsäure mit pharmazeutischer Aktivität, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
JPH02101010A (ja) * 1988-10-07 1990-04-12 Kashiwa Kagaku Kogyo:Kk 人体皮膚散布薬剤
ATE138389T1 (de) 1991-02-11 1996-06-15 Fidia Spa Gellanester
JP3310994B2 (ja) * 1991-07-03 2002-08-05 電気化学工業株式会社 アレルギー治療剤
IT1264321B (it) * 1992-01-13 1996-09-23 Mini Ricerca Scient Tecnolog Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie
IT1264322B (it) 1992-07-30 1996-09-23 Lanfranco Callegaro Esteri di gellano autoreticolato, procedimento di preparazione e loro applicazioni farmaceutiche e biomedico-sanitarie
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses

Also Published As

Publication number Publication date
WO1995003786A2 (en) 1995-02-09
DE69434992D1 (de) 2007-08-02
ES2288298T3 (es) 2008-01-01
US20020132790A1 (en) 2002-09-19
DE69434992T2 (de) 2007-12-06
US6509322B2 (en) 2003-01-21
ITPD930165A1 (it) 1995-01-30
AU7534194A (en) 1995-02-28
IT1263394B (it) 1996-08-05
EP0716596A1 (de) 1996-06-19
EP0716596B1 (de) 2007-06-20
PT716596E (pt) 2007-08-20
WO1995003786A3 (en) 1995-03-16
ITPD930165A0 (it) 1993-07-30
EP0716596B8 (de) 2007-10-03

Similar Documents

Publication Publication Date Title
ATE365033T1 (de) Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung
CA2095223A1 (en) Topical compositions for transdermal delivery of prodrug derivatives of morphine
ES2330516T3 (es) Composicion para el tratamiento de la ictiosis que utiliza la antitripsina.
US20150374641A1 (en) Film-forming pharmaceutical composition for wound healing and method for preparing the same
AR002030A1 (es) Composiciones farmaceuticas para administracion a la piel o a las mucosas, y uso de una combinacion de aciclovir e hidrocortisona para la elaboracion de medicamentos
ATE144414T1 (de) Felbinac enthaltendes arzneimittel
KR20080035024A (ko) 환자에게 피부병 약제를 투여하는 방법
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
ATE451096T1 (de) Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel
CA2921957A1 (en) Compositions, methods and systems for the treatment of cutaneous disorders
JP2004507496A5 (de)
EP4103769A1 (de) Natürliche zusammensetzung auf der basis von polymeren zum elektrospinnen und verfahren zu deren herstellung
US5795575A (en) Topical medicament which increases the number of capillaries in damaged skin
US7083781B2 (en) Film forming polymers, methods of use, and devices and applications thereof
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
US20180116986A1 (en) Composition of novel powder formulations of tranexamic acid
WO2001013955A1 (en) Film forming polymers, methods of use, and devices and applications thereof
JP2003517448A (ja) 肥厚性皮膚の酵素による処置および予防
JPH03291222A (ja) ジクロフェナック・ナトリウムを含有する局所用医薬組成物
US20220031715A1 (en) Compositions and methods for enhancing wound healing
EE9900346A (et) Viljatusevastane ja viljastumisvõimet tõstev ravim
RU2517213C2 (ru) Средство пептидной структуры, обладающее противовоспалительным, антибактериальным, ранозаживляющим, регенеративным, анальгетическим, противоожоговым действием и лекарственные формы на его основе
KR20170082942A (ko) 냄새 제거제가 구비된 파스
AR012872A1 (es) Uso del mometanosulfonato del acido (e)-alfa-[2-n-butil-1-[(carboxifenil)metil]-1-h-imidazol-5- il]metilen-2-tiofenpropionico para la fabricacion de un medicamento ycomposicion farmaceutica que lo comprende para tratar hipertension sistolica aislada.
CN103370056A (zh) 具有止痛活性的吸收性敷料

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0716596

Country of ref document: EP